Nutritional Status and Dietary Intakes of The Patients With Mild-To-Moderate Alzheimer's Disease

被引：0

作者：

Fernando, Malika ^{[1
]}

Marliya, Thasmeeha ^{[2
]}

Raeesa, Fathima ^{[2
]}

Williams, Shehan ^{[1
]}

Silva, Renuka ^{[2
]}

机构：

[1] Univ Kelaniya, Fac Med, Dept Psychiat, Colombo, Sri Lanka

[2] Wayamba Univ Sri Lanka, Fac Livestock Fisheries & Nutr, Dept Appl Nutr, Kuliyapitiya, Sri Lanka

来源：

ANNALS OF NUTRITION AND METABOLISM | 2019年 / 75卷

关键词：

Alzheimer's Disease; Nutritional status; Dietary intakes; Micronutrients;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

828

引用

页码：294 / 294

页数：1

共 50 条

[41] Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials
Lu, Thuy V.
Grill, Joshua D.
Gillen, Daniel L.
JOURNAL OF ALZHEIMERS DISEASE, 2024, 98 (02) : 729 - 738
[42] Nutritional status according to the stages of Alzheimer’s disease
Larissa Vieira Marino
Liliana Figueiredo Andrade de Oliveira Ramos
Paula Garcia Chiarello
Aging Clinical and Experimental Research, 2015, 27 : 507 - 513
[43] Nutritional status according to the stages of Alzheimer's disease
Marino, Larissa Vieira
Andrade de Oliveira Ramos, Liliana Figueiredo
Chiarello, Paula Garcia
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 27 (04) : 507 - 513
[44] Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks
Guthrie, Heather
Honig, Lawrence S.
Lin, Helen
Sink, Kaycee M.
Blondeau, Kathleen
Quartino, Angelica
Dolton, Michael
Carrasco-Triguero, Montserrat
Lian, Qinshu
Bittner, Tobias
Clayton, David
Smith, Jillian
Ostrowitzki, Susanne
JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (03) : 967 - 979
[45] Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study
Gauthier, S.
Aisen, P. S.
Ferris, S. H.
Saumier, D.
Duong, A.
Haine, D.
Garceau, D.
Suhy, J.
Oh, J.
Lau, W.
Sampalis, J.
JOURNAL OF NUTRITION HEALTH & AGING, 2009, 13 (06) : 550 - 557
[46] The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
Kobayashi, Hisanori
Ohnishi, Takashi
Nakagawa, Ryoko
Yoshizawa, Kazutake
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 31 (08) : 892 - 904
[47] Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine fuzhisan
Bi, Min
Tong, Suijun
Zhang, Zhaoxu
Ma, Qilin
Zhang, Shiyang
Luo, Zuomin
Zhang, Yidan
Li, Xuling
Wang, Desheng
NEUROSCIENCE LETTERS, 2011, 501 (01) : 35 - 40
[48] Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
Michael F. Egan
Yuki Mukai
Tiffini Voss
James Kost
Julie Stone
Christine Furtek
Erin Mahoney
Jeffrey L. Cummings
Pierre N. Tariot
Paul S. Aisen
Bruno Vellas
Christopher Lines
David Michelson
Alzheimer's Research & Therapy, 11
[49] Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease
Egan, Michael F.
Mukai, Yuki
Voss, Tiffini
Kost, James
Stone, Julie
Furtek, Christine
Mahoney, Erin
Cummings, Jeffrey L.
Tariot, Pierre N.
Aisen, Paul S.
Vellas, Bruno
Lines, Christopher
Michelson, David
ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
[50] Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
S. Gauthier
P. S. Aisen
S. H. Ferris
D. Saumier
A. Duong
D. Haine
D. Garceau
J. Suhy
J. Oh
W. Lau
J. Sampalis
JNHA - The Journal of Nutrition, Health and Aging, 2009, 13 : 550 - 557

← 1 2 3 4 5 →